科研製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/11/02 | 4,140 | 4,260 | 4,140 | 4,205 | +100 | +2.4% | 135,600 |
2020/10/30 | 4,195 | 4,195 | 4,090 | 4,105 | -110 | -2.6% | 112,900 |
2020/10/29 | 4,190 | 4,230 | 4,170 | 4,215 | +30 | +0.7% | 173,900 |
2020/10/28 | 4,280 | 4,285 | 4,140 | 4,185 | -135 | -3.1% | 149,300 |
2020/10/27 | 4,350 | 4,350 | 4,290 | 4,320 | -35 | -0.8% | 162,600 |
2020/10/26 | 4,360 | 4,445 | 4,340 | 4,355 | -20 | -0.5% | 75,900 |
2020/10/23 | 4,375 | 4,395 | 4,365 | 4,375 | -20 | -0.5% | 80,500 |
2020/10/22 | 4,425 | 4,435 | 4,390 | 4,395 | -85 | -1.9% | 87,600 |
2020/10/21 | 4,445 | 4,505 | 4,435 | 4,480 | +30 | +0.7% | 74,800 |
2020/10/20 | 4,450 | 4,475 | 4,425 | 4,450 | -15 | -0.3% | 259,800 |
2020/10/19 | 4,435 | 4,490 | 4,430 | 4,465 | +65 | +1.5% | 82,000 |
2020/10/16 | 4,420 | 4,450 | 4,385 | 4,400 | -80 | -1.8% | 122,800 |
2020/10/15 | 4,535 | 4,545 | 4,475 | 4,480 | -75 | -1.6% | 179,100 |
2020/10/14 | 4,560 | 4,585 | 4,515 | 4,555 | ±0 | ±0% | 249,800 |
2020/10/13 | 4,620 | 4,630 | 4,555 | 4,555 | -45 | -1% | 96,800 |
2020/10/12 | 4,620 | 4,630 | 4,565 | 4,600 | -20 | -0.4% | 97,500 |
2020/10/09 | 4,695 | 4,695 | 4,610 | 4,620 | -75 | -1.6% | 137,900 |
2020/10/08 | 4,695 | 4,700 | 4,655 | 4,695 | +25 | +0.5% | 116,000 |
2020/10/07 | 4,675 | 4,695 | 4,655 | 4,670 | -75 | -1.6% | 93,800 |
2020/10/06 | 4,765 | 4,770 | 4,695 | 4,745 | +30 | +0.6% | 96,100 |
2020/10/05 | 4,720 | 4,800 | 4,705 | 4,715 | +5 | +0.1% | 95,300 |
2020/10/02 | 4,830 | 4,865 | 4,700 | 4,710 | - | - | 149,300 |
2020/10/01 | 0 | 0 | 0 | 0 | - | - | 0 |
2020/09/30 | 4,910 | 4,955 | 4,820 | 4,820 | -95 | -1.9% | 108,200 |
2020/09/29 | 4,880 | 4,940 | 4,830 | 4,915 | -35 | -0.7% | 125,400 |
2020/09/28 | 4,970 | 4,980 | 4,885 | 4,950 | +85 | +1.7% | 127,300 |
2020/09/25 | 4,890 | 4,910 | 4,845 | 4,865 | -15 | -0.3% | 102,500 |
2020/09/24 | 4,840 | 4,890 | 4,835 | 4,880 | +30 | +0.6% | 96,200 |
2020/09/23 | 4,900 | 4,925 | 4,840 | 4,850 | -55 | -1.1% | 191,700 |
2020/09/18 | 4,870 | 4,920 | 4,840 | 4,905 | +45 | +0.9% | 284,300 |
2020/09/17 | 4,785 | 4,865 | 4,785 | 4,860 | +65 | +1.4% | 137,000 |
2020/09/16 | 4,805 | 4,840 | 4,785 | 4,795 | -25 | -0.5% | 117,400 |
2020/09/15 | 4,830 | 4,840 | 4,780 | 4,820 | -15 | -0.3% | 130,200 |
2020/09/14 | 4,790 | 4,905 | 4,790 | 4,835 | +65 | +1.4% | 141,100 |
2020/09/11 | 4,730 | 4,810 | 4,700 | 4,770 | +50 | +1.1% | 149,700 |
2020/09/10 | 4,715 | 4,745 | 4,675 | 4,720 | +40 | +0.9% | 139,000 |
2020/09/09 | 4,665 | 4,685 | 4,575 | 4,680 | -195 | -4% | 392,800 |
2020/09/08 | 4,825 | 4,880 | 4,810 | 4,875 | +50 | +1% | 71,800 |
2020/09/07 | 4,815 | 4,845 | 4,805 | 4,825 | -35 | -0.7% | 167,800 |
2020/09/04 | 4,880 | 4,880 | 4,825 | 4,860 | -45 | -0.9% | 102,100 |
2020/09/03 | 4,965 | 4,965 | 4,875 | 4,905 | -20 | -0.4% | 94,300 |
2020/09/02 | 4,930 | 4,930 | 4,840 | 4,925 | -30 | -0.6% | 143,000 |
2020/09/01 | 4,945 | 4,970 | 4,910 | 4,955 | +55 | +1.1% | 108,800 |
2020/08/31 | 4,945 | 4,955 | 4,895 | 4,900 | +10 | +0.2% | 207,000 |
2020/08/28 | 5,000 | 5,020 | 4,840 | 4,890 | -60 | -1.2% | 128,700 |
2020/08/27 | 4,970 | 5,020 | 4,950 | 4,950 | -80 | -1.6% | 111,100 |
2020/08/26 | 5,010 | 5,030 | 4,965 | 5,030 | ±0 | ±0% | 96,800 |
2020/08/25 | 5,070 | 5,090 | 5,030 | 5,030 | -40 | -0.8% | 100,700 |
2020/08/24 | 5,030 | 5,080 | 5,010 | 5,070 | ±0 | ±0% | 64,000 |
2020/08/21 | 5,090 | 5,130 | 5,060 | 5,070 | -10 | -0.2% | 66,400 |
1101~
1150
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
科研薬 | 407,200円 | +30.5% | +111.0% | 4.67% | 11.48倍 | 1.00倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
日本新薬 | 373,500円 | +7.9% | +8.9% | 3.32% | 7.99倍 | 1.07倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
サワイGHD | 203,300円 | +4.0% | +25.4% | 2.61% | 8.89倍 | 1.17倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
キッセイ薬 | 379,500円 | +14.5% | -2.3% | 2.37% | 13.88倍 | 0.74倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
サンバイオ | 229,900円 | - | - | 0.00% | - | 106.48倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム